Oncolytics Biotech ONCY
NASDAQ ONCY
$0.50 -0.01 (-1.96%)
At close: Oct 22, 2026 · 4:00 PM EDT

Oncolytics Biotech (ONCY) Change in Accured Expenses (2009 - 2010)

Updated

Oncolytics Biotech (ONCY) reported Change in Accured Expenses of -$360,000 for FY2025, compared with $884,000 in FY2024.

Analysis

Oncolytics Biotech (ONCY) Change in Accured Expenses (2009 - 2010) Analysis & Trends

  • According to Business Quant data, Change in Accured Expenses came in at $884,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 2.41 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 1.20 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 338.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Oncolytics Biotech 59.75 Mn 30.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 2.50 Mn
Dec 31, 2009 -307,178.00
API Access

Oncolytics Biotech Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ONCY&period=max&api_key=YOUR_API_KEY